Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperandrogenism
ADR ID BADD_A06324
ADR Hierarchy
05      Endocrine disorders
05.05      Endocrine disorders of gonadal function
05.05.04      Endocrine abnormalities of gonadal function NEC
05.05.04.006      Hyperandrogenism
21      Reproductive system and breast disorders
21.03      Sexual function and fertility disorders
21.03.02      Sexual function and fertility disorders NEC
21.03.02.023      Hyperandrogenism
Description A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION. [MeSH]
MedDRA Code 10065597
MeSH ID D017588
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hyperandrogenism | Hyperandrogenemia | Hyperandrogenaemia | Testosterone excess | Excessive secretion of testosterone
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00898Finasteride0.000090%
BADD_D02329Valproic acid--
The 1th Page    1    Total 1 Pages